-
Specialties
Board Certification
American Board of Dermatology (Dermatology)Patient Rating
5.0 /5( out of 1131 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
September 30, 2025MIDVALLEYDr. Mark Eliason is the best! Thorough, professional, takes his time to explain everything!
September 20, 2025SUGAR HOUSE HEALTH CENTERHis medical skills are superlative, but his concerns for the whole person he sees as a patient alre even better.
September 16, 2025MIDVALLEYExcellent dermatologist and person. He listens , very knowledgeable, kind and cares about his patients
September 05, 2025SUGAR HOUSE HEALTH CENTERDr Eliason and staff made me felt comfortable and well taken care of. Spent the time to listen to me and answer all of my questions re: skin care etc.
September 02, 2025SUGAR HOUSE HEALTH CENTERDr. Eliason is an amazing doctor. I am lucky to have him for my dermatologist!
August 31, 2025SUGAR HOUSE HEALTH CENTERMark is a best-in-class dermatologist who cares about his patients.
August 30, 2025MIDVALLEYDr. Mark Eliason is an excellent doctor. he is thorough, explains everything and cares about his patients. i would recommend him to anyone and have recommended him to my family and friends.
August 26, 2025MIDVALLEYIf the survey had an option like, 'Phenominal', I would have picked that!
August 23, 2025MIDVALLEYHe is the best!!
-
Board Certification and Academic Information
Academic Departments Dermatology -Professor (Clinical)
Board Certification American Board of Dermatology (Dermatology)Education history
Residency Dermatology - University of Utah School of Medicine Resident Research Fellow Familial Melanoma - Huntsman Cancer Institute Research Fellow Internship Internal Medicine - University of Utah School of Medicine Intern Professional Medical Medicine - University of California - Irvine M.D. Undergraduate Molecular Biology - Brigham Young University B.S. Selected Publications
Journal Article
- Carlisle RP, Flint ND, Hopkins ZH, Eliason MJ, Duffin KC, Secrest AM (2020). Administrative Burden and Costs of Prior Authorizations in a Dermatology Department. JAMA Dermatol, 156(10), 1074-1078. (Read full publication)
- Forbes B, Secrest AM, Hand MQ, Eliason MJ (2018). Process of Post-operative Telephone Follow-up Implementation for Mohs Micrographic Surgery: A Pilot Study. J Clin Aesthet Dermatol, 11(7), 36-39. (Read full publication)
- Clark JJ, Woodcock A, Cipriano SD, Hyde MA, Edwards SL, Frost CJ, Eliason MJ (2016). Community perceptions about the use of black salve. J Am Acad Dermatol, 74(5), 1021-3. (Read full publication)
- Eliason MJ, Sontheimer RD (2015). How to reduce out-of-pocket costs for prescription medications.LID - 13030/qt5bk5n1vj [pii]. Dermatol Online J, 21(6). (Read full publication)
- Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD (2012). A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol, 67(4), 680-6. (Read full publication)
- Pho LN, Eliason MJ, Regruto M, Hull CM, Powell DL (2011). Treatment of chronic urticaria with colchicine. J Drugs Dermatol, 10(12), 1423-8. (Read full publication)
- Pho LN, Smith FJ, Konecki D, Bale S, McLean WH, Cohen B, Eliason MJ, Leachman SA (2011). Paternal germ cell mosaicism in autosomal dominant pachyonychia congenita. Arch Dermatol, 147(9), 1077-80. (Read full publication)
- Wilson LH, Eliason MJ, Leiferman KM, Hull CM, Powell DL (2011). Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors. J Am Acad Dermatol, 64(6), 1221-2. (Read full publication)
- McLean WH, Hansen CD, Eliason MJ, Smith FJ (2011). The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol, 131(5), 1015-7. (Read full publication)
- Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, Hansen CD, Eliason MJ, Srivatsa GS, Kornbrust DJ, Smith FJ, McLean WI, Milstone LM, Kaspar RL (2010). First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther, 18(2), 442-6. (Read full publication)
- Eliason MJ, Bowen GM, Bowen AR, Hazzard L, Samlowski WE (2009). Primary Treatment of Verrucous Carcinoma of the Penis with 5-fluorouracil, cis-diamino-dichloro platinum and Radiation Therapy Arch Derm). Arch Dermatol, 145(11), 1291.
- Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA (2007). Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. J Invest Dermatol, 127(1), 183-8. (Read full publication)
- Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA (2006). Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol, 126(3), 660-6. (Read full publication)
Review
- Millsop JW, Heller MM, Eliason MJ, Murase JE (2013). Dermatological medication effects on male fertility. [Review]. Dermatol Ther, 26(4), 337-46. (Read full publication)
- Leachman SA, Jackson R, Eliason MJ, Larson AA, Bolognia JL (2007). Management of melanoma during pregnancy. [Review]. Dermatol Nurs, 19(2), 145-52, 161. (Read full publication)
Case Report
- Eliason MJ, Hansen CB, Hart M, Porter-Gill P, Chen W, Sturm RA, Bowen G, Florell SR, Harris RM, Cannon-Albright LA, Swinyer L, Leachman SA (2007). Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol, 143(11), 1409-12. (Read full publication)
Letter
- Houston NA, Secrest AM, Harris RJ, Mori WS, Eliason MJ, Phillips CM, Ferris LK (2016). Patient Preferences During Skin Cancer Screening Examination. [Letter to the editor]. JAMA Dermatol, 152(9), 1052-4. (Read full publication)
- Clark JJ, Secrest AM, Hull CM, Eliason MJ, Leiferman KM, Gleich GJ, Powell DL (2016). The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review. [Letter to the editor]. J Am Acad Dermatol, 74(6), 1274-6. (Read full publication)
- Eliason M, Bowen G, Bowen A, Hazard L, Samlowski W (2009). Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy. [Letter to the editor]. Arch Dermatol, 145(8), 950-2. (Read full publication)
-
(
out of
1131
reviews
)